Genetic variation in the renin--angiotensin system, use of renin--angiotensin system inhibitors and the risk of myocardial infarction
Maitland-van der Zee et al.
Journal of Renin-Angiotensin-Aldosterone System 2011;12:208-214.
ABSTRACT
Impaired relaxation of cerebral arteries in the absence of elevated salt intake in normotensive congenic rats carrying the Dahl salt-sensitive renin gene
Durand et al.
Am. J. Physiol. Heart Circ. Physiol. 2010;299:H1865-H1874.
ABSTRACT
| FULL TEXT
Management of High Blood Pressure in Blacks: An Update of the International Society on Hypertension in Blacks Consensus Statement
Flack et al.
Hypertension 2010;56:780-800.
ABSTRACT
| FULL TEXT
Racial Analysis of Patients With Myocardial Infarction Complicated by Heart Failure and/or Left Ventricular Dysfunction Treated With Valsartan, Captopril, or Both
Prisant et al.
J Am Coll Cardiol 2008;51:1865-1871.
ABSTRACT
| FULL TEXT
Management of hypertension in ethnic minorities
Khan and Beevers
Heart 2005;91:1105-1109.
FULL TEXT
Comparison of Monotherapy with Irbesartan 150 mg or Amlodipine 5 mg for Treatment of Mild-to-Moderate Hypertension
Neutel et al.
Journal of Renin-Angiotensin-Aldosterone System 2005;6:84-89.
ABSTRACT
Outcomes in Hypertensive Black and Nonblack Patients Treated With Chlorthalidone, Amlodipine, and Lisinopril
Wright et al.
JAMA 2005;293:1595-1608.
ABSTRACT
| FULL TEXT
Heart failure--the importance of ethnicity
Sosin et al.
Eur J Heart Fail 2004;6:831-843.
ABSTRACT
| FULL TEXT
Systematic Review: Antihypertensive Drug Therapy in Black Patients
Brewster et al.
ANN INTERN MED 2004;141:614-627.
ABSTRACT
| FULL TEXT
Determinants of Blood Pressure Response to Quinapril in Black and White Hypertensive Patients: The Quinapril Titration Interval Management Evaluation Trial
Mokwe et al.
Hypertension 2004;43:1202-1207.
ABSTRACT
| FULL TEXT
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian et al.
Hypertension 2003;42:1206-1252.
ABSTRACT
| FULL TEXT
`Size is not everything`: the Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT): The ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. Major outcomes in high-risk hypertensive patients randomised to angiotensin-converting enzyme inhibitor or calcium channel blocker versus diuretic. The Antihypertensive and Lipid-Lowering treatment to prevent Heart Attack Trial (ALLHAT)
Mcinnes
British Journal of Diabetes & Vascular Disease 2003;3:263-267.
ABSTRACT
Efficacy and tolerability of eplerenone and losartan in hypertensive black and white patients
Flack et al.
J Am Coll Cardiol 2003;41:1148-1155.
ABSTRACT
| FULL TEXT
Management of High Blood Pressure in African Americans: Consensus Statement of the Hypertension in African Americans Working Group of the International Society on Hypertension in Blacks
Douglas et al.
Arch Intern Med 2003;163:525-541.
FULL TEXT
Major Outcomes in High-Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)
The ALLHAT Officers and Coordinators for the ALLHA
JAMA 2002;288:2981-2997.
ABSTRACT
| FULL TEXT
Outlook for the Development of Fixed Combination Antihypertensive Agents in Japan
Ishii
Drug Information Journal 2001;35:589-598.
ABSTRACT
Angiotensin II Receptor Blockers: Equal or Preferred Substitutes for ACE Inhibitors?
Grossman et al.
Arch Intern Med 2000;160:1905-1911.
FULL TEXT
The management of hypertensive disease in Black patients
Gibbs et al.
QJM 1999;92:187-192.
ABSTRACT
| FULL TEXT
Comparison of the Efficacy of Dihydropyridine Calcium Channel Blockers in African American Patients With Hypertension
Hall et al.
Arch Intern Med 1998;158:2029-2034.
ABSTRACT
| FULL TEXT
Influence of Race and Dietary Salt on the Antihypertensive Efficacy of an Angiotensin-Converting Enzyme Inhibitor or a Calcium Channel Antagonist in Salt-Sensitive Hypertensives
Weir et al.
Hypertension 1998;31:1088-1096.
ABSTRACT
| FULL TEXT
Effect of Calcium Channel or -Blockade on the Progression of Diabetic Nephropathy in African Americans
Bakris et al.
Hypertension 1997;29:744-750.
ABSTRACT
| FULL TEXT
Efficacy and Tolerance of Antihypertensive Treatment in Men and Women With Stage 1 Diastolic Hypertension: Results of the Treatment of Mild Hypertension Study
Lewis et al.
Arch Intern Med 1996;156:377-385.
ABSTRACT
Differing Mechanisms of Action of Angiotensin-Converting Enzyme Inhibition in Black and White Hypertensive Patients
Weir et al.
Hypertension 1995;26:124-130.
ABSTRACT
| FULL TEXT
Angiotensin-Converting Enzyme Inhibitors in Hypertension: A Dozen Years of Experience
Materson and Preston
Arch Intern Med 1994;154:513-523.
ABSTRACT
Can We Prevent End-Stage Renal Disease due to Hypertension or to Diabetes Mellitus?
Luke
JAMA 1992;268:3119-3120.
ABSTRACT
Calcium Antagonists in Elderly and Black Hypertensive Patients: Therapeutic Controversies
Zing et al.
Arch Intern Med 1991;151:2154-2162.
ABSTRACT
A Randomized Controlled Trial of the Effects of Three Antihypertensive Agents on Blood Pressure Control and Quality of Life in Older Women
Applegate et al.
Arch Intern Med 1991;151:1817-1823.
ABSTRACT
Hypertensive Black Men and Women
Croog et al.
Arch Intern Med 1990;150:1733-1741.
ABSTRACT
